Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures

References

• Berger J R, Nath A. Remedies for HIV-associated peripheral neuropathy. Neurology 2000; 54: 2037–2038
   Google Scholar
• Bruce-Keller A J, Chauhan A, Dimayuga F O, Gee J, Keller J N, Nath A. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci 2003; 23: 8417–8422
   Google Scholar
• Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005; 6: 889–898
   PubMed Web of Science ®Google Scholar
• Cossarizza A TL, Mussini C. Mitochondria and HIV infection: the first decade. J Biol Regulators Homeostatic Agents 2002; 16: 18–24
   Google Scholar
• Dalakas M, Semino-Mora C, Leon-Monzon M. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC). Lab Invest 2001; 81: 1537–1544
   PubMed Web of Science ®Google Scholar
• Dolin R, Amato D A, Fischl M A, Pettinelli C, Beltangady M, Liou S H, Brown M J, Cross A P, Hirsch M S, Hardy W D. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. Arch Intern Med 1995; 155: 961–74
   PubMed Web of Science ®Google Scholar
• Famularo G MS, Marcellini S, Trinchieri V, Tzanfzoglou S, Santini G, Longo A, De Simone C. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 1997; 11: 185–190
   PubMed Web of Science ®Google Scholar
• Fischl M, Richman D D, Grieco M H, Gottlieb M S, Volberding P A, Laskin O L, Leedom J M, Groopman J E, Mildvan D, Schooley R T, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185–191
   PubMed Web of Science ®Google Scholar
• Havlir D, Tierney C, Friedland G H, Pollard R B, Smeaton L, Sommadossi J P, Fox L, Kessler H, Fife K H, Richman D D. In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis 2000; 182: 321–325
   PubMed Web of Science ®Google Scholar
• Hol E, Sodaar P, Bar P R. Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspects. Ann N Y Acad Sci 1994; 739: 74–86
   Google Scholar
• Joseph E, Chen X, Khasar S G, Levine J D. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 2004; 107: 147–158
   PubMed Web of Science ®Google Scholar
• Katzenstein D A, Hammer S M, Hughes M D, Gundacker H, Jackson J B, Fiscus S, Rasheed S, Elbeik T, Reichman R, Japour A, Merigan T C, Hirsch M S. The AIDS Clinical Trials Group Study 175 Virology Study Team (1996). The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med, 335: 1091–1098
   Google Scholar
• Keswani S CCB, Hasan C, Griffin J W, McArthur J C, Hoke A. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann Neurol 2003a; 53: 57–64
   PubMed Web of Science ®Google Scholar
• Keswani S C, Leitz G J, Hoke A. Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett 2004; 371: 102–105
   Google Scholar
• Keswani S CPC, Cherry C L, Hoke A, McArthur J C. HIV-associated sensory neuropathies. AIDS 2002; 16: 2105–2117
   PubMed Web of Science ®Google Scholar
• Keswani S CPM, Pardo C A, Griffin J W, McArthur J C, Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003b; 54: 287–296
   PubMed Web of Science ®Google Scholar
• Ma M, Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 1997; 71: 2495–2499
   PubMed Web of Science ®Google Scholar
• Masliah E, Ge N, Morey M, DeTeresa R, Terry R D, Wiley C A. Cortical dendritic pathology in human deficiency virus encephalitis. Lab Invest 1992; 66: 285–291
   PubMed Web of Science ®Google Scholar
• Mattson M, Haughey N J, Nath A. Cell death in HIV dementia. Cell Death Differ 2005; 893–904, Online
   Google Scholar
• McArthur J. HIV dementia: an evolving disease. J Neuroimmunol 2004; 157: 3–10
   PubMed Web of Science ®Google Scholar
• McArthur J C, Brew B J, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543–555
   PubMed Web of Science ®Google Scholar
• Melli G, Keswani S C, Fischer A, Chen W, Hoke A. Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. Brain 2006; 129: 1330–1338
   PubMed Web of Science ®Google Scholar
• Moyle G. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. Antiviral Ther 2005; 10: M47–M52, (Suppl 2)
   PubMedGoogle Scholar
• Nath A, Conant K, Chen P, Scott C, Major E O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenonmenon. J Biol Chem 1999; 274: 17098–17102
   PubMed Web of Science ®Google Scholar
• Nath A, Hartloper V, Furer M, Fowke K R. Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J Neuropathol Exp Neurol 1995; 54: 320–30
   PubMed Web of Science ®Google Scholar
• Nosheny R L, Bachis A, Acquas E, Mocchetti I. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur J Neurosci 2004; 20: 2857–2864
   Google Scholar
• Pardo C A, McArthur J C, Griffin J W. HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease. J Periph Nerv Syst 2001; 6: 21–27
   PubMed Web of Science ®Google Scholar
• Popovic M, Read-Connole E, Gallo R C. T4 positive hman neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet 1984; 2: 1472–1473
   Google Scholar
• Ratner L, Patarca R, Livak K J, Starcich B, Josephs S F, Doran E R, Rfalski J A, Whitehorn E A, Baumeister K, Ivanoff L, Petteway S R, Jr, Pearson M L, Lautenberger J A, Papas T S, Ghrayab J, Chang N T, Gallo R C, Wong-Staal F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985; 313: 277–283
   PubMed Web of Science ®Google Scholar
• Skuta G, Fischer G M, Janaky T, Kele Z, Szabo P, Tozser J, Sumegi B. Molecular mechanism of the short-term cardiotoxicity caused by dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem Pharmacol 1999; 58: 1915–1925
   Google Scholar
• Walker U, Setzer B, Venhoff N. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 2002; 16: 2165–2173
   PubMed Web of Science ®Google Scholar